Cancer BiologybioRxivPreprint
Reverse molecular pharmacology identifies the non-canonical axis of IRAK as a chemoresistance factor in neuroblastoma
Marion Le Grand, Chen Buxbaum, Mathilde Kerhervé…·Eddy Pasquier
This study identifies IRAK1 as a chemoresistance factor in neuroblastoma and shows synergy between IRAK1 inhibition and various drugs in preclinical models.
DOI 10.64898/2026.01.09.697473